Machine learning models (LASSO, SVM-RFE, and RF) identified 5 upregulated biomarkers—MMP9, Siglec-5, DYSF, MGAM, and S100A12—showing potential as diagnostic biomarkers for BPD. Here, S100A12 is linked to bronchopulmonary dysplasia.